INTERNATIONAL STEM CELL CORPORATION — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$2M↓-11.9%
2025-09-30$2M↑+8.7%$57K↑+145.6%4.0%
2025-06-30$2M↑+5.0%$129K↑+8.4%6.8%
2025-03-31$2M↑+0.0%$-256K↓-19.6%-10.1%
2024-12-31$2M↑+29.5%$11K0.9%
2024-09-30$2M↑+10.4%$-125K↑+4.6%-4.1%
2024-06-30$2M↑+26.6%$119K↓-75.8%6.4%
2024-03-31$2M↑+2.1%$-214K↓-529.4%-8.4%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$2M
↓-11.9% -$291K YoY
Net Income
$823K

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Go deeper